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Activated retina-specific T cells that have acquired
the ability to break through the blood-retinal barrier
are thought to be causally involved in autoimmune
uveitis, a major cause of human blindness. It is un-
clear where these autoreactive T cells first become
activated, given that their cognate antigens are
sequestered within the immune-privileged eye. We
demonstrate in a novel mousemodel of spontaneous
uveitis that activation of retina-specific T cells is
dependent on gut commensal microbiota. Retina-
specific T cell activation involved signaling through
the autoreactive T cell receptor (TCR) in response
to non-cognate antigen in the intestine andwas inde-
pendent of the endogenous retinal autoantigen. Our
findings not only have implications for the etiology
of human uveitis, but also raise the possibility that
activation of autoreactive TCRs by commensal mi-
crobes might be a more common trigger of autoim-
mune diseases than is currently appreciated.
INTRODUCTION
The skin and mucosal surfaces are densely populated by
different kinds of commensal microorganisms that include bac-
teria, fungi, and viruses that have co-evolved with their verte-
brate hosts duringmillions of years. Recently it has become clear
that commensals affect multiple aspects of host physiology and
homeostasis, including the normal development and functioning
of the immune system (for reviews see Cerf-Bensussan and
Gaboriau-Routhiau, 2010; Hooper et al., 2012). Consequently,
dysregulation of the endogenous microbiota can have profound
effects on host immune function (Lee et al., 2011; Proal et al.,
2009; Round and Mazmanian, 2009; Turnbaugh and Gordon,2009; Wen et al., 2008). The contribution of gut commensal
microbiota to development of inflammatory and autoimmune
diseases has been studied in various animal models (Berer
et al., 2011; Garrett et al., 2010; Wu et al., 2010). A number of
microorganisms, including Klebsiella pneumoniae, Proteus mira-
bilis, and segmented filamentous bacteria (SFB), have been
implicated as necessary, and in some cases sufficient (Garrett
et al., 2010; Wu et al., 2010). However, although it is well estab-
lished that IL-17-producing T cells are activated by microbial
components in the gut environment (Ivanov et al., 2009; Wu
et al., 2010), it is unclear how this relates to activation of tissue-
specific autoimmune T cells. The recently published evidence
that the Th17 cells elicited by SFB are actually specific to SFB
antigens (Goto et al., 2014; Yang et al., 2014) makes the connec-
tion to tissue-specific pathology even less clear.
An extra layer of complexity arises for immune-privileged
sites, whose antigens are separated from the immune system
by blood-tissue barriers. The eye is the prototypic immune-priv-
ileged tissue, but nevertheless it is subject to destructive auto-
immunity (Caspi, 2010). Autoimmune uveitis is a major cause
of blindness, having incidence similar to that of multiple sclerosis
and accounting for up to 15% of severe visual handicap in the
Western world (Durrani et al., 2004; Gritz and Wong, 2004).
The disease affects the working-age population and has a sig-
nificant public health impact. Patients often have detectable im-
mune responses to unique retinal proteins involved in visual
function such as retinal arrestin and interphotoreceptor retinoid
binding protein (IRBP), which, upon immunization of laboratory
rodents, elicit experimental autoimmune uveitis (EAU) (Caspi,
2010). However, unlike the experimental disease, most cases
of human uveitis cannot be connected to an exposure of the
immune system to ocular antigens. This presents a paradox,
because in order to enter the healthy eye through the blood-
retinal barrier, the pathogenic T cells must first be activated,
but the target antigens are sequestered within the eye and are
not expressed in the periphery (Gonzalez-Fernandez et al.,
1993). It therefore remains a major unresolved question where
such retina-specific T cells become activated. To address this,Immunity 43, 343–353, August 18, 2015 ª2015 Elsevier Inc. 343
we recently developed mice that express the R161 T cell recep-
tor (TCR) specific to residues 161–180 of IRBP, a major uveito-
genic epitope for uveitis-susceptible B10.RIII mice (Horai et al.,
2013). Mice of the R161H line spontaneously develop uveitis
starting around weaning age and reach 100% incidence by
2 months, making them a robust and reproducible model of
autoimmune uveitis (Horai et al., 2013).
In the present study we used the R161H mouse model of
uveitis to study natural triggers of the disease. Our data indicate
that a microbiota-dependent signal activates retina-specific
T cells in the gut lamina propria that precedes clinical onset of
the disease in the eyes. More importantly, activation of these
T cells is independent of the endogenous antigen and involves
signaling through the clonotypic autoreactive TCR by micro-
biota-dependent stimuli. Our study thus uncovers a novel mech-
anism whereby engagement of the specific TCR by non-cognate
stimuli in the gut activates autoreactive T cells and contributes to
autoimmune disease.
RESULTS
Spontaneous Uveitis in R161H Mice Is Associated with
an Enhanced Th17 Phenotype in the Gut
R161H mice develop uveitis spontaneously around weaning age
(4 weeks old), reaching peak disease around 12 weeks (Fig-
ures 1A and 1B). In an attempt to define when and where the
pathogenic cells become activated, thus acquiring the ability to
actively cross the blood-retinal barrier, we searched for T cells
with an activated phenotype in different tissues of young
(4-week-old) and adult (12-week-old) R161H mice. Although
4-week-old R161H mice had minimal or no detectable clinical
disease and minimal ocular leukocytic infiltrate, they displayed
high percentages of T cells with an activated/memory phenotype
(CD44hiCD62Llo) in the small and large intestinal lamina prop-
ria (LP). This was in sharp contrast to peripheral lymphoid
tissues, including the eye-draining submandibular lymph nodes
(Figure 1C). Furthermore, these T cells could produce IL-17A
(Figure 1D), a cytokine that previous studies identified as
pathogenic in autoimmune uveitis (Chi et al., 2008; Luger et al.,
2008; Wang et al., 2012). To directly visualize the activation
in vivo, we crossed the R161H mice to Nr4a1GFP reporter mice,
in which intensity of GFP fluorescence reflects the level of
Nur77 expression, and hence the strength of antigen receptor
signaling (Moran et al., 2011). As early as 17 days of age, and
well before clinical onset of disease, GFP signal in freshly ex-
planted intestinal tissue of R161H-Nr4a1GFP mice was promi-
nent, especially in the ileum, compared to ‘‘polyclonal’’Nr4a1GFP
controls (Figure 1E and Movies S1 and S2) and was similar in in-
tensity to the signal in adult R161H mice (Figure 1F and Movies
S3 and S4). In contrast, the GFP signal in the submandibular
lymph nodes as well as other peripheral lymph nodes was not
enhanced (Figure S1). Collectively, these data support the notion
that activation of T cells in the gut of R161H mice precedes the
clinical onset of disease.
Elimination of Commensals Attenuates Uveitis and
Reduces Activation of Th17 Cells in the Intestine
Th17 cells are a pathogenic effector lineage in the EAU
model, and an elevated Th17-cell-mediated response was re-344 Immunity 43, 343–353, August 18, 2015 ª2015 Elsevier Inc.ported to correlate with disease in uveitis patients (Chi et al.,
2008; Luger et al., 2008; Wang et al., 2012). Several reports
have shown the importance of gut commensal microbiota for
development of Th17 cells (see Hooper et al., 2012, for review).
In view of the high frequency of activated T cells producing
IL-17A in the intestinal LP of R161H mice shown in Figure 1, it
was logical to ask whether gut commensals might play a role
in disease in the spontaneous uveitis model. R161H mice were
treated with a broad-spectrum antibiotic cocktail (AMNV: ampi-
cillin, metronidazole, neomycin, and vancomycin) in drinking
water (Rakoff-Nahoum et al., 2004). Because R161H mice can
begin to show signs of disease around weaning age, treatment
was given to the breeders and the offspring were continued on
the treatment after weaning. In line with results published by
others, analysis of fecal material from AMNV-treated mice
showed a reduction in total bacterial mass by several orders
of magnitude and a reduced community complexity (Figures
S2A and S2B). Weekly fundus examination showed that devel-
opment of spontaneous uveitis was significantly delayed in
AMNV-treated R161H mice compared to the untreated group
(Figure 2A). Although ultimately most AMNV-treated R161H
mice developed some clinical signs, their disease scores were
drastically attenuated, as seen by histopathology of eyes
collected at 9–12 weeks of age, when disease in untreated
controls reaches its peak. This was recapitulated in R161H
mice reared under germ-free (GF) conditions (Figures 2B–2D).
AMNV treatment also decreased the GFP signal in the freshly
isolated intestine of R161H Nr4a1GFP mice (Figure 2E), confirm-
ing that gut microbiota are required for stimulation. In parallel,
frequency of IL-17A-producing T cells in the small intestine
and colonic LP of AMNV-treated R161H mice was reduced,
whereas IFN-g and IL-22 were reduced in the small intestine,
but not in the colon (Figures 2F and 2G). The frequency of
IL-17A+ T cells was also strongly attenuated in small intestine
and colon of GF R161H mice (Figure 2G). There was no expan-
sion of Foxp3+ cells as a result of AMNV treatment (Figures
S2C and S2D).
Even though the consequences of microbiota depletion in
our R161H mice were compatible with the results of others,
it was nevertheless important to consider whether prolonged
treatment with antibiotics or deficient development of the
immune system in a GF environment could account for the
observed attenuation of disease. Evidence against this notion
was provided by the fact that neither frequencies of IRBP-
specific T cells nor their proliferative responses were altered
between untreated and AMNV-treated R161H mice, or be-
tween SPF and GF-R161H mice (Figures S3A–S3D). Finally,
we examined the ability of the AMNV-treated WT littermates
(R161H mice are bred heterozygously) to develop uveitis after
active immunization with IRBP161-180. Disease scores 2 weeks
after immunization of AMNV-treated compared to untreated
WT littermates were not reduced (Figure S3E). In addition,
lymphocytes from these WT mice responded to antigen-spe-
cific or non-specific stimuli similarly, regardless of the treat-
ment (Figures S3F and S3G). In the aggregate, these results
confirm that attenuation of spontaneous uveitis in antibi-
otic-treated and GF R161H mice was due to depletion of
commensal microbiota and not to any alterations in immune
function.
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Figure 1. R161H Mice Develop Spontaneous Uveitis that Is Associated with Presence of Activated T Cells in the Gut
(A) Spontaneous uveitis in R161H mice. Fundus photography (left) and histology (right) of healthy WT and uveitic R161H retina.
(B) Kinetics of disease development in R161Hmice. Clinical scores were determined weekly by fundus examination. Mean ± SEM of 12–45 mice per time point is
shown.
(C and D) R161H CD4+ T cells in the intestine show an effector/memory phenotype. Representative CD4+ T cell plots for activation/memory markers (C) and Th17
cell phenotype (D) in various tissues from 4-week-old (clinical score % 0.25) and 12-week-old (clinical score 1.5) mice. Intracellular IL-17A and IFN-g were
detected after 4 hr ex vivo stimulation with PMA and ionomycin in the presence of Brefeldin A. Abbreviations are as follows: SI, small intestine; LI, large
intestine (colon).
(E and F) Expression ofNr4a1 (encodingNur77) was detected byGFP (green) in fresh ileum samples ofNr4a1GFP reporter mice at 17 days of age (E, before disease
onset) and adult (F, after onset). Single plane of the Z stack is shown.
Also see Figure S1 and Movies S1, S2, S3, and S4.
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Figure 2. Elimination of Commensal Micro-
biota in R161H Mice Attenuates Sponta-
neous Uveitis and Reduces the Th17 Cells
in the Gut
(A) Delayed onset of spontaneous uveitis in
AMNV-treated versus untreated R161H mice by
weekly fundoscopic analysis. **p < 0.005 by 2-way
ANOVA.
(B) Histology scores of untreated (None) and
AMNV-treated R161H mice (9–12 weeks old).
(C) Histology scores of age-matched untreated
SPF and germ-free (GF) R161H mice (combined
data from 7 and 11 weeks old). ***p < 0.0001 by
Mann-Whitney U test.
(D) Representative histopathology of SPF, AMNV-
treated, and GF R161H mice (original magnifica-
tion, 2003).
(E) Expression of GFP in fresh ileum samples of
R161H Nr4a1GFP mice treated or not with AMNV.
Images are representative single plane of the
Z stack. Scale bars represent 25 mm.
(F) Representative plots of cytokine-producing
LP CD4+ T cells from R161H mice treated, or not,
with AMNV.
(G) Compiled data for (F) from at least five experi-
ments (4–16 weeks old, 2–3 mice were pooled per
group in each plot). ***p < 0.0001, **p < 0.005,
*p < 0.05, n.s., not significant.
(H) Frequencies of IL-17A-producing LP CD4+
T cells from SPF R161H and GF R161H mice.
Data compiled from two experiments. **p < 0.01,
*p < 0.05. Red horizontal lines (B, C, G, H) denote
group means.
Also see Figures S2 and S3.R161H T Cells in the Gut Preferentially Exhibit a Th17
Phenotype Compared to Polyclonal T Cells
To elucidate a possible connection between increased fre-
quency of IL-17A-producing cells in the intestine of R161H
mice and spontaneous uveitis, we compared frequencies of
IL-17A-producing cells in intestine of R161H mice with their
healthy WT littermates. Compared to the WT mice, CD4+
T cells isolated from either small or large intestine LP of
R161H mice displayed much higher frequencies of IL-17A-pro-
ducing cells after a short PMA and ionomycin pulse (Figures 3A
and 3B). Essentially identical results were seen directly ex vivo
using Il17aGFP reporter knock-in mice crossed onto the R161H
background. In the next step, we compared the frequency of
IL-17A-producing cells in the IRBP-specific versus the non-
IRBP-specific CD4+ T cells isolated from intestinal LP of the346 Immunity 43, 343–353, August 18, 2015 ª2015 Elsevier Inc.same R161H mouse. The mice co-
expressed the Il17aGFP reporter and
T cells bearing the IRBP-specific R161H
TCR were detected with an IRBP161-180-
MHCII-IgG dimer (p161 dimer) (Karabe-
kian et al., 2005). The p161 dimer-posi-
tive population contained a much higher
proportion of Th17 cells, as defined by
dual IL-17A-GFP and CCR6 positivity,
than the dimer-negative population, a
pattern highly reminiscent of cells iso-
lated from uveitic eyes of the samemice (Figures 3C and 3D). Notably, because the Il17aGFP re-
porter obviates the need for PMA and ionomycin stimulation
ex vivo, the observed difference is considered to reflect the
actual in vivo situation. Furthermore, whereas the proportion
of p161 dimer+ T cells in the total CD4+ population remains
fairly constant in untreated, AMNV-treated, and GF mice (Fig-
ure S3), the proportion of antigen-experienced cells within
the dimer+ population (CD44hiCD62Llo) was markedly more
frequent in the gut than in peripheral lymphoid tissues, and
that proportion was reduced by AMNV treatment or GF condi-
tions (Figures 3E and 3F). Together, these results indicate that
the clonotypic R161H T cells express a Th17 cell phenotype in
the gut environment more readily than do non-IRBP-specific
T cells, similarly to their status in the eye where their cognate
antigen is found.
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Figure 3. Retina-Specific T Cells Preferen-
tially Exhibit an Antigen-Experienced, Th17
Phenotype in the Intestine of R161H Mice
(A) The frequency of Th17 cells is enhanced in the
intestine of R161H mice compared to their WT
littermates. Representative plots of small intestine
and colonic LP CD4+ cells from 8-week-old mice
for intracellular IL-17A and IFN-g staining after 4 hr
ex vivo stimulation with PMA and ionomycin in the
presence of Brefeldin A.
(B) Compiled data from several experiments for
small intestine and colon (two mice from each
genotype were pooled as a sample). *p < 0.05,
**p < 0.01, ***p < 0.001.
(C) IL-17A (GFP) and CCR6 expression of freshly
isolated cells from intestinal LP and uveitic eyes in
CD4+ p161 dimer+ and dimer populations. One
representative experiment of two (in which two
mice were pooled per sample) is shown.
(D) Compiled data from individual small intestines
of three additional experiments. *p < 0.05 by
Mann-Whitney U test. Red horizontal lines (B, D)
are group means.
(E and F) Proportions of memory (CD44hiCD62Llo)
and naive (CD44loCD62Lhi) within the dimer+
or dimer populations of CD4+ T cells from LP
compared to peripheral lymphoid tissues in (E)
SPF R161H mice and (F) AMNV-treated and GF
R161H mice (CD44loCD62Llo and CD44hiCD62Lhi
populations are not displayed). Mean ± SEM of
4–12 mice is shown.R161H T Cell Activation in the Intestine Is Independent
of Endogenous IRBP Expression
We next asked whether the high frequency of Th17 cells in the
gut LP of R161H mice is dependent on endogenous IRBP. To-
ward that end, we crossed R161H mice to Rbp3/mice, which
lack expression of IRBP (Liou et al., 1998). R161H-Rbp3/mice
do not develop uveitis, due to lack of the target antigen in their
eyes (Figure 4A), but IRBP-specific T cells are present and are
functionally responsive to IRBP (Figure S4A), and transfer of
the activated cells induces severe uveitis in naive WT recipient
mice (Figure 4B). These mice still had an increased frequency
of IL-17A+ T cells in their small intestine and colon LP, compara-
ble to the R161H IRBP-sufficient mice and much higher than
WT mice (Figures 4C and 4D), indicating that endogenous
IRBP is not required for activation of IRBP-specific T cells in
the gut of R161H mice.
In addition to the cognate antigen, T cells can be stimulated
through their TCR also by superantigens, which activate broad
classes of TCRs by binding to the TCR Vb chain outside of the
antigen-binding region (Fraser and Proft, 2008). We therefore
examined a number of commercially available superantigens
for the ability to stimulate R161H cells. The R161H TCR is Vb1/Immunity 43, 343–353Va17 (Horai et al., 2013). Staphylococcal
enterotoxins B (SEB), SED, and SEI,
which are all reported to bind Vb1, did
not induce proliferation of R161H T cells,
although they induced vigorous prolifera-
tion of WT T cells (Figure 4E). Although
we cannot categorically exclude involve-ment of an as yet uncharacterized superantigen, the evidence
speaks against activation of the R161 clonotypic TCR by a
superantigen.
Retina-Specific T Cells in the Intestine Receive a Signal
through Their Clonotypic TCR
The data thus far strongly implied involvement of the R161 TCR
in activation of the uveitogenic T cells in the intestine by gut
commensals. To directly demonstrate presence of TCR signaling
in the IRBP-specific T cells within the gut environment, we exam-
ined co-localization of p161 dimer with TCR signaling indica-
tors in ileal tissue sections. By immunofluorescent staining,
p161 dimer co-localized with the GFP signal in R161H-Nr4a1GFP
mice (Figure 5A), or with tyrosine-phosphorylated Zap-70, a
proximal signaling molecule downstream of the TCR, in R161H
mice (Figure 5B). These results confirmed TCR signaling by acti-
vation of two different downstream molecules. Nevertheless,
because T cells (normal or TCR Tg) can express a second TCR
due to incomplete exclusion of the TCRa chain (Hardardottir
et al., 1995; He et al., 2002), we had to exclude the possibility
that the R161H cells were being activated through a putative
second TCR. Toward that end, we crossed the R161H mice to, August 18, 2015 ª2015 Elsevier Inc. 347
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Figure 4. R161H T Cell Activation in the Intestine Is Not Dependent
on Endogenous IRBP or Bacterial Superantigen
(A) Rbp3/ R161H mice do not develop spontaneous uveitis, due to lack of
the target retinal Ag.
(B) Activated R161H Rbp3/ T cells induce uveitis in WT naive recipients.
(C) The high proportion of IL-17A-producing CD4+ T cells in the LP compared
to WT is maintained in R161H Rbp3/mice. Data shown are from one of four
experiments with similar results.
(D) Compiled data from individual small intestines in four additional experi-
ments. **p < 0.005, ***p < 0.001 byMann-Whitney U test. Red lines indicate the
mean of the group.
(E) IRBP-specific T cells do not proliferate in response to com-
mercially available purified enterotoxins with known Vb specificities.
CD4+ T cells isolated from lymph nodes of WT or R161H mice on the
Rbp3/ background were stimulated with 100 ng/ml of the indicated
superantigen.
348 Immunity 43, 343–353, August 18, 2015 ª2015 Elsevier Inc.Tcra/ mice, which lack endogenous TCRab-expressing CD4+
T cells (Yoshitomi et al., 2005). R161H-Tcra/ mice develop
uveitis that is at least as severe as that developed by their
R161H-Tcra+/+ littermates (Figure S5A). Flow cytometric analysis
confirmed that all CD4+ T cells in these mice stained with
p161 dimer (Figures S5B and S5C). Co-localization of phos-
pho-Zap-70 with CD4 was clearly detectable in CD4+ cells in
the small intestine of R161H-Tcra/ animals (Figure 5C) and
these T cells appeared to be high producers of IL-17A (Figures
5D, 5E, S5D, and S5E). These results demonstrate that CD4+
T cells in the gut signal through their clonotypic retina-specific
R161H TCR.
Signals Derived from Intestinal Microbiota Activate
Retina-Specific T Cells for Pathogenicity
To examine whether signals derived from gut microbiota are able
to activate retina-specific T cells to cause uveitis, we first asked
whether transfer of GF mice to SPF housing conditions would
restore characteristic development of uveitis. R161H-GF ani-
mals at 4 weeks of age were co-housed with R161H-SPF ani-
mals and disease development wasmonitored by weekly fundus
examination. Ex-GF R161H mice transferred to SPF conditions
developed uveitis with similar kinetics and similar final histology
scores to R161H-SPF controls (Figures 6A and 6B).
Next, we examined whether bacteria-rich protein extracts
from gut contents would directly activate IRBP-specific T cells
in vitro and trigger their pathogenic potential. Extracts were
prepared from bacteria-rich intestinal contents of R161H mice
and were used to activate T cells from peripheral lymph nodes
of R161H mice in vitro. The IRBP-specific (dimer-positive)
T cells upregulated expression of the activation marker CD69
much more vigorously than did the nonspecific (dimer-negative)
population from the same mouse, in a dose-dependent fashion
(Figure 6C). IL-2 production, generally considered to indicate a
T cell response to antigen, was inhibited by an anti-MHC class
II antibody (Figure 6D), suggesting that the activation signal
was received via TCR-MHC interactions. In contrast, innate stim-
uli alone (LPS and extract ofM. tuberculosis) did not cause acti-
vation (Figure 6E). To further strengthen the notion of priming in
the gut by non-cognate antigen, we cultured R161H Rbp3/
lymph node cells with the extract. As before, the clonotypic
T cells responded with CD69 upregulation and IL-2 production
to the intestinal extract (Figures S6A and S6B) but not to
innate stimuli alone (Figures S6B and S6C). Next, to confirm
that a protein component in the extracts is necessary for activa-
tion of retina-specific T cells, the extracts were subjected to
proteinase K treatment or heat denaturation and presented
to naive CD44loCD62LhiCD69CD25 T cells from R161H
Rbp3/Rag2/ mice (only R161 TCR) by splenic CD11c+
APCs from WT or Rbp3/ mice (Figures 6G, S6E, and S6F).
Naive R161H T cells responded to the untreated extract highly
significantly, though less vigorously than total clonotype-positive
T cells. Importantly, activation did not occur to LPS alone andAbbreviations are as follows: SEB, Staphylococcal enterotoxin B; SEI,
Staphylococcal enterotoxin I; SED, Staphylococcal enterotoxin D; TSST-1,
toxic shock syndrome toxin-1. Positive control: IRBP161-180 (1 mg/ml). Prolif-
eration was assayed as 3H-thymidine uptake. Also see Figure S4. Error bars
represent SEM of the replicates.
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Figure 5. Retina-Specific T Cells in the Intestine Receive a TCR
Signal through Their Clonotypic TCR
(A) Nr4a1GFP and R161H Nr4a1GFP LP samples were co-stained with the p161
dimer (red). GFP alone is shown in the inset (blue, Hoechst 33342; white,
phalloidin).
(B) Detection of phospho-Zap70 (pZap70, green) and p161 dimer (red) in the
gut LP of WT or R161Hmice. Arrow shows a double-positive cell in the overlay
(blue, Hoechst 33342).was significantly reduced by proteinase K treatment as well
as by heat denaturation. Finally, to confirm requirement for
bacteria, we examined intestinal content extracts from GF
compared to SPF R161H mice for their ability to activate the
naive clonotypic T cells from Rbp3/ donors. Extracts from
GF mice, normalized per gram contents, were much less stimu-
latory than those of SPF mice (Figures 6H and S6G). In all cases,
APCs isolated from WT and Rbp3/ mice, which lack the
cognate antigen, provided equivalent stimulation. Because in-
testinal contents of GF mice contained much less protein than
those of SPF mice (1.0 ± 0.14 versus 14.3 ± 1.3 mg/ml, probably
due to lack of microbial content), we also normalized the amount
of extracts in the cultures by protein concentration, with the
same outcome (Figure S6H). These results strongly support the
conclusion that R161 T cells respond to protein component(s)
from gut commensal bacteria and not from the cognate or an un-
known endogenous Ag.
Finally, to connect intestinal stimuli to the disease process,
we examined whether exposure to extracts of bacteria-rich in-
testinal contents could make R161H cells pathogenic. R161H
T cells infused into naive WT recipients do not trigger disease
unless they are activated before transfer (Horai et al., 2013).
Notably, R161H lymph node cells cultured with extracts of intes-
tinal contents induced EAU in 40%–86% of WT recipient mice
within 6–10 days of transfer, whereas no disease was observed
within this time frame in recipients of non-activated R161H cells
(either freshly isolated or cultured without intestinal extracts)
(Figure 6I). Thus, gut microbe-rich protein extracts contained
the necessary and sufficient stimuli to make R161H T cells
capable of breaching the intact blood-retinal barrier and causing
uveitis.
DISCUSSION
A number of studies have documented the ability of gut com-
mensals to affect the expression of autoimmunity at proximal
as well as distal sites. The effects can be inhibitory, such as dia-
betes in NOD mice (Markle et al., 2013; Wen et al., 2008), but
more often are enhancing, such as several models of arthritis,
EAE, and colitis (Berer et al., 2011; Chappert et al., 2013; Gar-
rett et al., 2010; Lee et al., 2011; Morton et al., 2014; Wu et al.,
2010; Yoshitomi et al., 2005). The mechanisms are complex and
might involve several unrelated microorganisms in concert (Gar-
rett et al., 2010). Induction of Th17 cell responses in the gut by
organisms such as SFB has been demonstrated in association
with autoimmunity (Ivanov et al., 2009), but it is unclear how the
responses observed in the intestinal tract translate to antigen-
specific immunity in the target tissue, especially in view of the
recent report that SFB-induced Th17 cells in the gut are SFB(C) pZap70 (green) co-localizes with CD4 staining (red) in gut LP of R161H-
Tcra/ mice. Sections of ileum. Double-positive cells are yellow (arrows and
inset).
Scale bars represent 5 mm.
(D) Small intestine LP of R161H Tcra/ mice. The high proportion of IL-17A-
producing CD4+ T cells compared to WT is maintained. Colon showed similar
data.
(E) Compiled data from individual small intestines in two repeat experiments.
Also see Figure S5.
Immunity 43, 343–353, August 18, 2015 ª2015 Elsevier Inc. 349
A B
C D
E F
G H I
Figure 6. Microbial Signal(s) from Intestinal
Contents Are Sufficient to Activate Retina-
Specific T Cells for Pathogenicity
(A) Sequential fundoscopy scores of ex-GF R161H
mice. GF R161H mice (n = 4) co-housed with SPF
mice (n = 6) after weaning. One representative
kinetic of two repeat experiments is shown. Error
bars represent SEM.
(B) Histological evaluation of ex-GF R161H mice at
the end of co-housing. Data from two experiments
(9-week-old and 12-week-old) are combined.
Control GF R161Hmice were obtained at 12 weeks
of age. **p < 0.005 by Mann-Whitney test.
(C) Induction of CD69 expression in CD4+ dimer+
versus dimer T cells from LN of R161H mice after
20 hr of stimulation with intestinal content extracts.
**p < 0.005 by 2-way ANOVA.
(D) IL-2 production by R161H lymphocytes in
response to the extracts in presence or absence of
anti-MHC class II Ab.
(E and F) Induction of CD69 expression in R161H
lymphocytes after 20 hr of stimulation with LPS (E)
or with M. tuberculosis (MTB) extract (F).
(G) Naive R161H Rbp3 /Rag2/ cells stimulated
with intestinal content extracts (Ext) treated or not
with proteinase K (PK) in presence of APCs (DCs)
from WT or Rbp3/ mice.
(H) Cultures as in (G), stimulated with intestinal
content extract from GF or SPF R161H donors.
*p < 0.05. (Note: related data shown in Figure S6.)
(I) R161H lymphocytes were cultured with the
protein-rich extracts of intestinal contents (Ext) for
3 days and indicated numbers of the cells were
injected into WT recipients. Shown are histology
scores in recipients on day 11. One representative
experiment of four is shown.specific (Goto et al., 2014; Yang et al., 2014). In the current
study, we present compelling evidence that autopathogenic
T cells that cause disease in a distal site receive a micro-
biota-dependent activation signal in the gut through their clo-
notypic TCR that is independent of the endogenous source
of the cognate antigen and precedes the clinical onset of
pathology.
The R161H mouse model recapitulates the spontaneous na-
ture of human uveitis, which makes it suitable for the study of
natural triggers of the disease (Horai et al., 2013). Moreover,
the target antigen is one of several known conserved retinal
proteins that elicit memory responses in uveitis patients and
are likely to be involved in disease pathology (Gery et al.,
1996). The spontaneous and highly penetrant nature of uveitis
in R161H mice appears to be due to their enhanced frequency
of retina-specific T cells (Horai et al., 2013), which amplify the
naturally low penetrance of uveitis to a frequency that can be
studied in the laboratory. To our knowledge, this is the first report
that directly links autoimmunity to the neuroretina and the break-
down of the immune privilege of the eye to normal commensal
microbes. Furthermore, our data offer a plausible explanation350 Immunity 43, 343–353, August 18, 2015 ª2015 Elsevier Inc.of the paradox that underlies uveitis,
where autoreactive T cells must be primed
by an antigen that is inaccessible to them
in order to elicit pathology, by identifyingthe commensal microbiome as source of non-cognate antigen
that can activate them in the periphery.
Although our data showing that autoreactive T cells receive a
signal in the gut through their clonotypic TCR appear compelling,
by themselves they do not prove that this is the initial site where
their activation occurs. Although at the present state of technol-
ogy we are unable to demonstrate that IRBP-specific R161H
Th17 cells detected in the gut have not ‘‘visited’’ and been
exposed to their cognate antigen in the eye, three lines of evi-
dence speak for activation in the gut as a primary triggering event
for pathogenicity: (1) high frequency of activated T cells in the gut
of R161H mice (as early as 17 days, the earliest point examined)
preceded their appearance in the eye and onset of clinical dis-
ease; (2) absence of endogenous antigen did not change the
high frequency of R161H T cell activation in the gut; and (3) our
previous data (Zhou et al., 2012) showed that priming of retina-
specific T cells within the ocular microenvironment results in
acquisition of tolerance rather than effector function. Similarly,
the tools currently do not exist to demonstrate that IRBP-specific
T cells, which have been to the gut, end up in the eye. Although
recently amethod to endoscopically photolabel T cells within the
gut has been described (Morton et al., 2014), several years of
backcrossing would be required to apply this technology to the
R161H model.
Although it appeared that the activation of T cells in the gut is
driven at least in part by an interaction with the IRBP-specific
TCR, independent of endogenous IRBP, this does not exclude
a role for innate microbial stimuli. Our data showed that IRBP-
specific T cells are activated by bacteria-rich intestinal contents
extracts more vigorously than polyclonal non-IRBP-specific
T cells and that their activation is MHC class II dependent.
Microbes have their own ‘‘built in’’ adjuvant effect and it is
likely that this contributes to activation for pathogenicity under
in vivo conditions, similarly to the innate signals provided by
mycobacteria in complete Freund’s adjuvant. In fact, previous
studies might have confused this with specific TCR effects. For
example, mimicry was proposed (but not supported by data) in
the case of spontaneous EAE. In contrast to the IRBP-specific
TCR, the endogenous myelin oligodendrocyte glycoprotein
autoantigen was in fact needed to cooperate with the microbiota
for autoreactive T and B cell activation (Berer et al., 2011). We
therefore believe that ours is the first direct demonstration of
the involvement of an autoreactive TCR, rather than an innate
response to conserved microbial components, in commensal
microbiota-dependent autoimmune disease expressed at a
distant site.
Identification of the causative microorganism(s) and dissection
of the microbial-derived antigen(s) that can trigger uveitis would
have far-reaching implications for therapy of uveitis. Although
our dataprovide strongevidence for a necessary role of theclono-
typic TCR, they do not identify the bacterial component(s) that
could serve as the non-cognate antigen(s). Our attempts to iden-
tify such an organism have thus far proved difficult. Treatment of
R161H mice with individual antibiotics composing the AMNV
cocktail, which in some cases were helpful to narrow down the
bacterial species involved (Ramanan et al., 2014), did not prove
fruitful, because the protective effect of each single antibiotic
was minimal (data not shown). We also examined a possible
role for SFB, which is present in our colony. Previous studies
showed thatmonocolonizationofGFmicewithSFB reconstituted
their ability to develop spontaneous arthritis (Wu et al., 2010) or
immunization-induced EAE (Lee et al., 2011). Depletion of SFB
from R161H mice by vancomycin treatment did not abrogate
spontaneous uveitis (data not shown). We would interpret these
data to mean that (1) the non-cognate antigen(s) that engage
the TCR in the gut can be expressed bymultiple bacterial species
and (2) the ‘‘deterministic’’ signal for T helper cell differentiation
whereby the innate milieu drives the direction of antigen-specific
T cell differentiation (also proposed by Goto et al., 2014; Yang
et al., 2014) can be provided not only by SFB, but also by other
commensal microorganisms. Monocolonization of GF R161H
mice with candidate microorganism(s) would be needed to iden-
tify the causative species. However, because of the complexity
of the commensal microbiota and the likely dependence of the
effects on a combination of species (as has already been docu-
mented even in the absence of an antigen-specific component
in the TRUC model of colitis [Garrett et al., 2010]), such an
approach is currently beyond the scope of this study.
Collectively, the data reported here provide strong evidence
that commensal microorganisms constitute a trigger and/oramplification signal to autoreactive T cells that drive sponta-
neous uveitis. Although our data do not exclude a role for innate
signals, which are always present in a microbial milieu and
might provide an adjuvant effect, they support a critical role for
signaling through the retina-specific clonotypic R161 TCR by
non-cognate antigen(s) derived from commensals or their prod-
ucts. Our findings have implications for pathogenesis of human
uveitis, as well as broader implications for autoimmunity in gen-
eral. Given the huge diversity of the endogenous microbiota, it
is conceivable that activation of autoreactive TCRs by cross-
reactive products derived from commensals is not restricted to
IRBP. Based on our data, we propose that triggering of autoreac-
tive TCRs by commensals might represent an underappreciated
mechanism in the etiology of autoimmune diseases.
EXPERIMENTAL PROCEDURES
Mice
IRBP-specific TCR transgenic (R161H) mice were generated on the B10.RIII
background as previously described (Horai et al., 2013). Rbp3/ mice (Liou
et al., 1998) (a kind gift from Dr. Gregory Liou, Medical College of Georgia),
Tcra/ mice (Mombaerts et al., 1992) (Taconic), Il17aGFP knock-in reporter
mice (Biocytogen, BCG-0001; Jackson #018472), and Nr4a1GFP reporter
mice (Moran et al., 2011) (a kind gift from Dr. Kristin Hogquist at University
of Minnesota) were backcrossed onto B10.RIII background and crossed to
R161H mice. Mice were maintained under SPF conditions at the National
Eye Institute, NIH. Germ-free R161H mice were rederived at Central Institute
for Experimental Animals (Kanagawa, Japan) and were maintained at Sankyo
Labo Service. Experimental protocols were approved by the Institutional Ani-
mal Care and Use Committee.
Evaluation of Spontaneous and Induced Ocular Disease
Development of uveitis was monitored by weekly fundoscopic observation via
a binocularmicroscope. For histopathology, eyeswere enucleated and fixed in
4% glutaraldehyde for 1 hr and transferred to 10% formaldehyde for at least
24 hr, embedded in methacrylate, and processed for H&E staining. Scores
were assigned by a masked observer on a scale of 0–4, according to the
criteria for EAU scoring described in detail elsewhere, based on the number,
size, and type of lesions (Horai and Caspi, 2010).
Isolation of Lamina Propria Lymphocytes
LP lymphocytes were isolated essentially as described, with modifications
(Atarashi et al., 2011; Scheiffele and Fuss, 2002), and are described in detail
in the Supplemental Experimental Procedures.
Flow Cytometric Analysis
Eyes were minced and treated with 1 mg/ml collagenase D for 30–45 min at
37C. Eye-infiltrating cells and lymphocytes isolated from tissues were resus-
pended in media for ex vivo stimulation, or directly in FACS buffer. Antibodies
and detailed methods are in the Supplemental Experimental Procedures. For
intracellular staining, cells were stimulated in complete RPMI + 10% FBS
with 10 ng/ml PMA, 500 ng/ml ionomycin, and Brefeldin A for 4 hr, fixed in
4% paraformaldehyde, and permeabilized with Triton buffer (0.5% Triton
X-100 + 0.1% BSA in PBS).
Depletion of Intestinal Commensals
Mice were treated with a broad-spectrum antibiotic cocktail of ampicillin,
metronidazole, neomycin, and vancomycin (AMNV) as described (Rakoff-
Nahoum et al., 2004). Treatment was given to pregnant dams and continued
after weaning. Control animals were housed in conventional set-ups on the
same rack.
Preparation of Intestinal Bacteria-Rich Protein Extracts
Intestines were flushed with cold PBS, contents were centrifuged at 2,0003 g
at 4C for 10 min, and supernatant was discarded. Pellets were resuspendedImmunity 43, 343–353, August 18, 2015 ª2015 Elsevier Inc. 351
to make 2 g fecal matter in 1 ml of PBS (2 g/ml) containing Aprotinin (10 mg/ml),
Leupeptin (10 mg/ml), and PMSF (0.5 mM) (Sigma), followed by 3 freeze-thaw
cycles at80C and room temperature for 20min to disrupt the bacterial cells.
Cell lysis was completed with a sonicator (Heat Systems) for five high-intensity
cycles of 30 s each on ice. Samples were then centrifuged at 14,0003 g at 4C
for 30min and the supernatant was collected and sterilized by filtration through
0.2 mm filter. Proteinase treatment was performed by incubating the extracts
with proteinase K (100 mg/ml; Fisher Scientific) at 55C overnight, followed
by 65C for 1 hr to inactivate the enzyme. Heat denaturation of the extracts
was at 95C for 15 min. Protein was quantitated by DC Protein Assay (BioRad)
per manufacturer’s instructions.
Proliferation Assays
For lymphocyte activation assays, 5 3 105 total lymph node cells or 2 3 105
FACS-sorted naive CD62LhiCD44loCD69CD25CD4+ T cells and MACS-
purified 105 splenic CD11c+ dendritic cells were placed in round-bottom
96-well plates in complete RPMI medium with 10% FBS and stimulated
with serial dilutions of protein-rich extracts from intestinal contents or
with IRBP161-180 for control. In some experiments, 10 mg/ml of anti-mouse
I-A/I-E mAb (clone M5/114.15.2) or rat IgG2b isotype control (BioLegend)
was added to the culture. Cells were harvested 20–24 hr after stimulation
for flow cytometry analysis and supernatants were collected for quantita-
tion of IL-2 by ELISA (R&D). For lymphocyte proliferation assays, 5 3 105
lymph node cells were cultured in triplicate in round-bottom 96-well
plates in complete RPMI with 10% FBS and stimulated with IRBP161-180
or superantigens SEB, SED, SEI, or TSST-1 at the indicated concen-
trations. After 48 hr, 1 mCi/well of [3H]thymidine was added for another
16–18 hr. Plates were harvested (Brandel) and counted by liquid scintillation
(PerkinElmer).
Adoptive Transfer
R161H lymph node cells were activated with intestinal contents (1:30 dilution)
in DMEM-10% FBS in the presence of recombinant mouse IL-12, recombinant
human IL-2 (Proleukin), and anti-IL-4 mAb (clone 11B11) for 3 days. After
removal of dead cells by centrifugation over Lympholyte-M (Cedarlane), 5 to
10 million lymphocytes were injected i.p. into naive WT recipient mice. Fundo-
scopic evaluation of disease was performed between days 4 and 12. Eyes
were collected on day 10–13 for histological examination and disease scoring,
as described above.
Ex Vivo Visualization of GFP-Expressing Cells in Intestinal Tissues
and Immunofluorescent Staining of Intestinal Sections
Ex vivo imaging of GFP-expressing cells of Nr4a1GFP reporter mice was done
on freshly collected tissues. All samples were kept on ice in PBS and placed
onto a glass-bottomed dish (MatTek Corporation) with mounting media Fluo-
romount-G (Southern Biotech) or Vectashield H-1000 (Vector Laboratories).
Intestines were opened longitudinally and placed with the lumen down. The
initial focal plane was chosen at 10 and 15 mm from the surface of the tissue
and Z stack data for movies was collected from 5 to 60 mm. Images were
acquired with 403 objective in inverted Zeiss LSM 700 or 780 confocal micro-
scope. Bright field contrast adjustments were applied and movies were
captured with Zen 2012 Lite software (Carl Zeiss). For immunofluorescence
(IF) staining, cleaned intestines were fixed in paraformaldehyde, passed
through 10% and 20% sucrose, and snap-frozen. Staining was performed
and images were acquired as described in detail in the Supplemental Experi-
mental Procedures.
Statistical Analysis
Statistical data analysis was done with GraphPad Prism v.6.0 (GraphPad Soft-
ware). Differences between groups were determined by Mann-Whitney test or
two-way ANOVA, as appropriate for the experiment. p values of < 0.05 were
considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, four movies, and Supplemental
Experimental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.immuni.2015.07.014.352 Immunity 43, 343–353, August 18, 2015 ª2015 Elsevier Inc.AUTHOR CONTRIBUTIONS
R.H. and C.R.Z.-B. designed and performed the experiments and analyzed the
data together. P.D.-P. designed imaging and intestinal content extraction pro-
tocol. Both P.D.-P. and J.L.K. carried out imaging experiments. J.C., P.B.S.,
and Y.J. provided experimental assistance including fundus examination
and genotyping. C.-C.C. evaluated histology slides. H.Y. and K.H. provided
expertise and access to the GF facility and helped to interpret the data.
R.R.C. conceptualized and supervised the study. R.H., C.R.Z.-B., and
R.R.C. wrote the manuscript.
ACKNOWLEDGMENTS
The authors thank Drs. Koji Atarashi (RIKEN) and Ivan Fuss (NIAID, NIH) for
sharing protocols, Dr. Kristin Hogquist (University of Minnesota) for Nr4a1GFP
reporter mice, Dr. Gregory Liou (Medical College of Georgia) forRbp3/mice,
all members of the R.R.C. lab for help and advice, NEI FlowCytometry Core for
assistance in cell sorting and analysis, NEI Genetic Engineering Core for the
assistance in antibiotics treatment and mouse colony maintenance, NEI His-
tology Core for processing of histology specimens, and NIH-DVR Pathology
andBacteriology labs for bacteriological analysis.We thank Drs. Silvio Gutkind
(NIDCR), William E. Paul (NIAID), Katsuko Sudo (Tokyo Medical University),
and Kikuji Itoh (Japan SLC) for support and useful discussions. R.R.C. is sup-
ported by NEI intramural funding (project # EY000184) and K.H. is supported
by CREST, Japan Science and Technology Agency (Tokyo, Japan).
Received: December 9, 2014
Revised: April 30, 2015
Accepted: May 21, 2015
Published: August 18, 2015
REFERENCES
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y.,
Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011). Induction of colonic
regulatory T cells by indigenous Clostridium species. Science 331, 337–341.
Berer, K., Mues,M., Koutrolos, M., Rasbi, Z.A., Boziki, M., Johner, C.,Wekerle,
H., and Krishnamoorthy, G. (2011). Commensal microbiota andmyelin autoan-
tigen cooperate to trigger autoimmune demyelination. Nature 479, 538–541.
Caspi, R.R. (2010). A look at autoimmunity and inflammation in the eye. J. Clin.
Invest. 120, 3073–3083.
Cerf-Bensussan, N., and Gaboriau-Routhiau, V. (2010). The immune system
and the gut microbiota: friends or foes? Nat. Rev. Immunol. 10, 735–744.
Chappert, P., Bouladoux, N., Naik, S., and Schwartz, R.H. (2013). Specific gut
commensal flora locally alters T cell tuning to endogenous ligands. Immunity
38, 1198–1210.
Chi, W., Zhu, X., Yang, P., Liu, X., Lin, X., Zhou, H., Huang, X., and Kijlstra, A.
(2008). Upregulated IL-23 and IL-17 in Behc¸et patients with active uveitis.
Invest. Ophthalmol. Vis. Sci. 49, 3058–3064.
Durrani, O.M., Meads, C.A., andMurray, P.I. (2004). Uveitis: a potentially blind-
ing disease. Ophthalmologica 218, 223–236.
Fraser, J.D., and Proft, T. (2008). The bacterial superantigen and superantigen-
like proteins. Immunol. Rev. 225, 226–243.
Garrett, W.S., Gallini, C.A., Yatsunenko, T., Michaud, M., DuBois, A., Delaney,
M.L., Punit, S., Karlsson, M., Bry, L., Glickman, J.N., et al. (2010).
Enterobacteriaceae act in concert with the gut microbiota to induce sponta-
neous and maternally transmitted colitis. Cell Host Microbe 8, 292–300.
Gery, I., Mochizuki, M., and Nussenblatt, R.B. (1996). Retinal specific antigens
and immunopathogenic processes they provoke. Prog. Retinal Res. 5, 75–109.
Gonzalez-Fernandez, F., Van Niel, E., Edmonds, C., Beaver, H., Nickerson,
J.M., Garcia-Fernandez, J.M., Campohiaro, P.A., and Foster, R.G. (1993).
Differential expression of interphotoreceptor retinoid-binding protein, opsin,
cellular retinaldehyde-binding protein, and basic fibroblastic growth factor.
Exp. Eye Res. 56, 411–427.
Goto, Y., Panea, C., Nakato, G., Cebula, A., Lee, C., Diez, M.G., Laufer, T.M.,
Ignatowicz, L., and Ivanov, I.I. (2014). Segmented filamentous bacteria
antigens presented by intestinal dendritic cells drive mucosal Th17 cell differ-
entiation. Immunity 40, 594–607.
Gritz, D.C., and Wong, I.G. (2004). Incidence and prevalence of uveitis in
Northern California; the Northern California Epidemiology of Uveitis Study.
Ophthalmology 111, 491–500, discussion 500.
Hardardottir, F., Baron, J.L., and Janeway, C.A., Jr. (1995). T cells with two
functional antigen-specific receptors. Proc. Natl. Acad. Sci. USA 92, 354–358.
He, X., Janeway, C.A., Jr., Levine,M., Robinson, E., Preston-Hurlburt, P., Viret,
C., andBottomly, K. (2002). Dual receptor T cells extend the immune repertoire
for foreign antigens. Nat. Immunol. 3, 127–134.
Hooper, L.V., Littman, D.R., and Macpherson, A.J. (2012). Interactions be-
tween the microbiota and the immune system. Science 336, 1268–1273.
Horai, R., and Caspi, R.R. (2010). Retinal inflammation: uveitis/uveoretinitis.
In Animal Models for Retinal Diseases, I.-H. Pang and A.F. Clark, eds.
(SpringerLink), pp. 207–225.
Horai, R., Silver, P.B., Chen, J., Agarwal, R.K., Chong,W.P., Jittayasothorn, Y.,
Mattapallil, M.J., Nguyen, S., Natarajan, K., Villasmil, R., et al. (2013).
Breakdown of immune privilege and spontaneous autoimmunity in mice ex-
pressing a transgenic T cell receptor specific for a retinal autoantigen.
J. Autoimmun. 44, 21–33.
Ivanov, I.I., Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., Wei, D.,
Goldfarb, K.C., Santee, C.A., Lynch, S.V., et al. (2009). Induction of intestinal
Th17 cells by segmented filamentous bacteria. Cell 139, 485–498.
Karabekian, Z., Lytton, S.D., Silver, P.B., Sergeev, Y.V., Schneck, J.P., and
Caspi, R.R. (2005). Antigen/MHC class II/Ig dimers for study of uveitogenic
T cells: IRBP p161-180 presented by both IA and IE molecules. Invest.
Ophthalmol. Vis. Sci. 46, 3769–3776.
Lee, Y.K., Menezes, J.S., Umesaki, Y., and Mazmanian, S.K. (2011).
Proinflammatory T-cell responses to gut microbiota promote experimental
autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 108 (Suppl 1 ),
4615–4622.
Liou, G.I., Fei, Y., Peachey, N.S., Matragoon, S., Wei, S., Blaner, W.S., Wang,
Y., Liu, C., Gottesman, M.E., and Ripps, H. (1998). Early onset photoreceptor
abnormalities induced by targeted disruption of the interphotoreceptor reti-
noid-binding protein gene. J. Neurosci. 18, 4511–4520.
Luger, D., Silver, P.B., Tang, J., Cua, D., Chen, Z., Iwakura, Y., Bowman, E.P.,
Sgambellone, N.M., Chan, C.C., and Caspi, R.R. (2008). Either a Th17 or a Th1
effector response can drive autoimmunity: conditions of disease induction
affect dominant effector category. J. Exp. Med. 205, 799–810.
Markle, J.G., Frank, D.N., Mortin-Toth, S., Robertson, C.E., Feazel, L.M.,
Rolle-Kampczyk, U., von Bergen, M., McCoy, K.D., Macpherson, A.J., and
Danska, J.S. (2013). Sex differences in the gut microbiome drive hormone-
dependent regulation of autoimmunity. Science 339, 1084–1088.
Mombaerts, P., Clarke, A.R., Rudnicki, M.A., Iacomini, J., Itohara, S., Lafaille,
J.J., Wang, L., Ichikawa, Y., Jaenisch, R., Hooper, M.L., et al. (1992). Mutations
in T-cell antigen receptor genes alpha and beta block thymocyte development
at different stages. Nature 360, 225–231.Moran, A.E., Holzapfel, K.L., Xing, Y., Cunningham, N.R., Maltzman, J.S.,
Punt, J., and Hogquist, K.A. (2011). T cell receptor signal strength in Treg
and iNKT cell development demonstrated by a novel fluorescent reporter
mouse. J. Exp. Med. 208, 1279–1289.
Morton, A.M., Sefik, E., Upadhyay, R., Weissleder, R., Benoist, C., andMathis,
D. (2014). Endoscopic photoconversion reveals unexpectedly broad leukocyte
trafficking to and from the gut. Proc. Natl. Acad. Sci. USA 111, 6696–6701.
Proal, A.D., Albert, P.J., andMarshall, T. (2009). Autoimmune disease in the era
of the metagenome. Autoimmun. Rev. 8, 677–681.
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., and
Medzhitov, R. (2004). Recognition of commensal microflora by toll-like recep-
tors is required for intestinal homeostasis. Cell 118, 229–241.
Ramanan, D., Tang, M.S., Bowcutt, R., Loke, P., and Cadwell, K. (2014).
Bacterial sensor Nod2 prevents inflammation of the small intestine by restrict-
ing the expansion of the commensal Bacteroides vulgatus. Immunity 41,
311–324.
Round, J.L., andMazmanian, S.K. (2009). The gut microbiota shapes intestinal
immune responses during health and disease. Nat. Rev. Immunol. 9, 313–323.
Scheiffele, F., and Fuss, I.J. (2002). Induction of TNBS colitis in mice. Curr.
Protoc. Immunol. Chapter 15. Unit 15.19.
Turnbaugh, P.J., and Gordon, J.I. (2009). The core gut microbiome, energy
balance and obesity. J. Physiol. 587, 4153–4158.
Wang, C., Tian, Y., Lei, B., Xiao, X., Ye, Z., Li, F., Kijlstra, A., and Yang, P.
(2012). Decreased IL-27 expression in association with an increased Th17
response in Vogt-Koyanagi-Harada disease. Invest. Ophthalmol. Vis. Sci.
53, 4668–4675.
Wen, L., Ley, R.E., Volchkov, P.Y., Stranges, P.B., Avanesyan, L.,
Stonebraker, A.C., Hu, C., Wong, F.S., Szot, G.L., Bluestone, J.A., et al.
(2008). Innate immunity and intestinal microbiota in the development of type
1 diabetes. Nature 455, 1109–1113.
Wu, H.J., Ivanov, I.I., Darce, J., Hattori, K., Shima, T., Umesaki, Y., Littman,
D.R., Benoist, C., and Mathis, D. (2010). Gut-residing segmented filamentous
bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32,
815–827.
Yang, Y., Torchinsky, M.B., Gobert, M., Xiong, H., Xu, M., Linehan, J.L.,
Alonzo, F., Ng, C., Chen, A., Lin, X., et al. (2014). Focused specificity of intes-
tinal TH17 cells towards commensal bacterial antigens. Nature 510, 152–156.
Yoshitomi, H., Sakaguchi, N., Kobayashi, K., Brown, G.D., Tagami, T.,
Sakihama, T., Hirota, K., Tanaka, S., Nomura, T., Miki, I., et al. (2005). A role
for fungal beta-glucans and their receptor Dectin-1 in the induction of autoim-
mune arthritis in genetically susceptible mice. J. Exp. Med. 201, 949–960.
Zhou, R., Horai, R., Silver, P.B., Mattapallil, M.J., Za´rate-Blade´s, C.R., Chong,
W.P., Chen, J., Rigden, R.C., Villasmil, R., and Caspi, R.R. (2012). The living
eye ‘‘disarms’’ uncommitted autoreactive T cells by converting them to
Foxp3(+) regulatory cells following local antigen recognition. J. Immunol.
188, 1742–1750.Immunity 43, 343–353, August 18, 2015 ª2015 Elsevier Inc. 353
